KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Other Accumulated Expenses (2016 - 2025)

Chemed (CHE) has 17 years of Other Accumulated Expenses data on record, last reported at $58.9 million in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 37.36% year-over-year to $58.9 million; the TTM value through Dec 2025 reached $58.9 million, up 37.36%, while the annual FY2025 figure was $58.9 million, 37.36% up from the prior year.
  • Other Accumulated Expenses reached $58.9 million in Q4 2025 per CHE's latest filing, down from $65.7 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $69.3 million in Q1 2023 and bottomed at $653000.0 in Q3 2022.
  • Average Other Accumulated Expenses over 5 years is $41.8 million, with a median of $45.3 million recorded in 2024.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 98.34% in 2022, then skyrocketed 8375.96% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $39.0 million in 2021, then surged by 49.91% to $58.5 million in 2022, then dropped by 5.03% to $55.6 million in 2023, then dropped by 22.85% to $42.9 million in 2024, then skyrocketed by 37.36% to $58.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $58.9 million in Q4 2025, $65.7 million in Q3 2025, and $47.7 million in Q2 2025.